Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

59.20

+2.31 (4.06%)

At close: Jun 26, 2026, 4:00 PM EDT

59.97

+0.77 (1.30%)

Pre-market: Jun 29, 2026, 8:08 AM EDT

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	189.95	165.6	183.58	107.95	122.72	122.47
Short-Term Investments	278.14	248.48	60.05	98.42	67.89	59.73
Cash & Short-Term Investments	468.09	414.07	243.63	206.37	190.61	182.2
Cash Growth	74.44%	69.96%	18.05%	8.27%	4.61%	-43.68%
Accounts Receivable	23.22	15.59	41.72	21.27	12.66	3.99
Other Receivables	-	-	-	-	7.66	-
Total Trade Receivables	23.22	15.59	41.72	21.27	20.32	3.99
Inventory	73.14	54.9	26.36	31.12	21.6	3.68
Other Current Assets	29.71	42.61	20.08	17.54	10.54	6.59
Total Current Assets	594.17	527.18	331.8	276.3	243.06	196.45
Net Property, Plant & Equipment	11.32	11.75	11.04	12.67	7.04	8.38
Other Intangible Assets	15	15.25	16.25	17.25	18.25	19.25
Other Long-Term Assets	204.79	209.46	221.47	220.11	191.32	8.72
Total Assets	825.28	763.63	580.55	526.32	459.67	232.8
Accounts Payable	24.4	2.03	2.04	8.25	7.9	1.87
Accrued Expenses	108.35	112.04	80.51	44.67	30.11	38.03
Current Portion of Leases	3.17	2.99	1.99	2.25	3.3	3.38
Unearned Revenue	-	-	-	0.31	-	-
Other Current Liabilities	20.69	22.13	16.08	8.19	5.75	1.54
Total Current Liabilities	156.61	139.18	100.62	63.67	47.07	44.82
Long-Term Leases	5.86	6.51	7.86	10.01	2.62	2.67
Other Long-Term Liabilities	57.13	50.33	33.63	13.81	13.84	0.27
Total Long-Term Liabilities	62.98	56.84	41.5	23.82	16.46	2.94
Total Liabilities	219.59	196.03	142.12	87.48	63.52	47.76
Common Stock	0.02	0.02	0.02	0	0.02	0.02
Additional Paid-in Capital	1,046	1,030	959.72	916.76	888.12	860.48
Accumulated Other Comprehensive Income	-0.67	-0.03	-0.16	0.01	0.04	-0.07
Retained Earnings	-439.55	-462.14	-521.14	-477.95	-492.03	-675.4
Shareholders' Equity	605.69	567.61	438.44	438.84	396.15	185.04
Total Liabilities & Equity	825.28	763.63	580.55	526.32	459.67	232.8
Total Debt	9.03	9.5	9.86	12.26	5.92	6.05
Net Cash (Debt)	459.07	404.58	233.77	194.11	184.69	176.15
Net Cash Growth	13.47%	73.06%	20.43%	5.10%	4.85%	-44.34%
Net Cash Per Share	5.70	5.12	3.27	2.70	2.62	2.57
Book Value	605.69	567.61	438.44	438.84	396.15	185.04
Book Value Per Share	7.53	7.19	6.14	6.10	5.63	2.70
Tangible Book Value	590.69	552.36	422.19	421.59	377.9	165.79
Tangible Book Value Per Share	7.34	6.99	5.91	5.86	5.37	2.42

SEC Filings: 10-K · 10-Q